| Drug Discovery and Production - What is benchtop NMR for and why use it? |
|
|
|
|
| |
|
| |
The latest drug discovery news from News Medical |
|
|
|
 | | |
__638376265172947961_multisizecolor_0_custom.jpg) Emerging Tools to Combat RSV!
CDC Updates for RSV：
The CDC now recommends Abrysvo, a RSV vaccine, for people who are 32-36 weeks pregnant to protect their babies from severe RSV infections. Earlier this year, the CDC also recommended Nirsevimab to protect babies.
Both medicines bind to the prefusion form of RSV, further emphasizing the value of structure-based antigen research. Explore ACROBiosystems' catalog of high-quality, structurally accurate virus proteins!
| |
|
|
| | |  | | |  A potential schizophrenia treatment discovered through the Warren Center for Neuroscience Drug Discovery has been cleared by the U.S. Food and Drug Administration for use in phase 1 clinical trials-;the third WCNDD therapeutic to reach that benchmark. | | | | |  The incorporation of CRISPR/Cas9 into clinical settings has promising applications for the future treatment of genetic disorders, human immunodeficiency virus (HIV) infection, and various malignant diseases. | | | | |  Simon Schröder has worked out how enzymes can be used to more easily form the desired bond between two nitrogen atoms. The building blocks for new drugs that help fight bacteria that are resistant to known antibiotics, for example, should be as cost-effective and environmentally friendly as possible. | | | | |  Combining a pair of experimental drugs may help treat malignant peripheral nerve sheath tumors with fewer harmful side effects, according to preliminary animal studies led by investigators at the Johns Hopkins Kimmel Cancer Center and Johns Hopkins Drug Discovery. | | | | |  Researchers assessed CSX-1004, a monoclonal antibody (mAb), for its efficacy in reversing fentanyl overdose based on its high affinity for fentanyl, positive animal model results, and safe pharmacokinetic profile, positioning it as a potential solution in the opioid crisis. | | | | |  A research team led by Hong Kong Baptist University (HKBU) has developed a novel drug delivery system for Alzheimer’s disease (AD). The researchers have engineered exosomes, extracellular vesicles released by cells, to effectively carry the bioactive compound Corynoxine-B extracted from the Chinese herbal medicine Gouteng to the brain of mice with AD. | |
|
|
| | | | How would you rate today's newsletter?
| |
|
|
|
|
|
|
|
__638380629267705552_multisizecolor_0_custom.jpg)
.png)
